Correlation Between Mineralys Therapeutics, and Cementos Pacasmayo

Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Cementos Pacasmayo at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Cementos Pacasmayo into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mineralys Therapeutics, Common and Cementos Pacasmayo SAA, you can compare the effects of market volatilities on Mineralys Therapeutics, and Cementos Pacasmayo and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Cementos Pacasmayo. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Cementos Pacasmayo.

Diversification Opportunities for Mineralys Therapeutics, and Cementos Pacasmayo

-0.07

Correlation Coefficient

Mineralys Therapeutics,  Cementos Pacasmayo

Good diversification

The 3 months correlation between Mineralys and Cementos is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Cementos Pacasmayo SAA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cementos Pacasmayo SAA and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Cementos Pacasmayo. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cementos Pacasmayo SAA has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Cementos Pacasmayo go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Cementos Pacasmayo

Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Cementos Pacasmayo. In addition to that, Mineralys Therapeutics, is 2.51 times more volatile than Cementos Pacasmayo SAA. It trades about 0.0 of its total potential returns per unit of risk. Cementos Pacasmayo SAA is currently generating about 0.04 per unit of volatility. If you would invest  444.00  in Cementos Pacasmayo SAA on October 26, 2024 and sell it today you would earn a total of  134.00  from holding Cementos Pacasmayo SAA or generate 30.18% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.39%
Values	Daily Returns

Mineralys Therapeutics, Common  vs.  Cementos Pacasmayo SAA

Mineralys Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mineralys Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Cementos Pacasmayo SAA

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Cementos Pacasmayo SAA are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, Cementos Pacasmayo is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Mineralys Therapeutics, and Cementos Pacasmayo

The main advantage of trading using opposite Mineralys Therapeutics, and Cementos Pacasmayo positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Cementos Pacasmayo can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cementos Pacasmayo will offset losses from the drop in Cementos Pacasmayo's long position.

The idea behind Mineralys Therapeutics, Common and Cementos Pacasmayo SAA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.